World's Best Scientists 2026 revealed!
Kristian Wachtell

Kristian Wachtell

D-Index & Metrics

Medicine

D-Index
75
Citations
25661
World Ranking
19030
National Ranking
9489

Overview

Kristian Wachtell is affiliated with Cornell University in the United States and has contributed extensively to medical research, focusing primarily on cardiology and cardiovascular medicine. Their work encompasses diverse subfields, including surgery, endocrinology, diabetes and metabolism, radiology, nuclear medicine and imaging, and biomedical engineering.

Their research is notably centered around several main topics, which include:

  • Blood Pressure and Hypertension Studies
  • Cardiac Valve Diseases and Treatments
  • Atrial Fibrillation Management and Outcomes
  • Cardiovascular Function and Risk Factors
  • Cardiac Imaging and Diagnostics
  • Heart Rate Variability and Autonomic Control
  • Mechanical Circulatory Support Devices

Kristian Wachtell has published frequently in several key medical journals, with notable recurring publication venues such as:

  • European Heart Journal
  • Journal of Hypertension
  • Hypertension
  • Exploration of Medicine
  • The Lancet

Co-authorship has been an important aspect of Wachtell's research output. Frequent collaborators include:

  • Sverre E. Kjeldsen
  • Stevo Julius
  • Peter M. Okin
  • Anders M. Greve
  • Richard B. Devereux

Among recent papers, Wachtell's contributions cover a range of cardiovascular topics, including:

  • Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure, 2021, The Lancet
  • Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock, 2024, New England Journal of Medicine
  • Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk, 2020, Circulation
  • Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis, 2021, The Lancet
  • Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis, 2021, The Lancet Oncology

Wachtell's publications reflect a consistent emphasis on investigating blood pressure management, cardiovascular risk factors, and interventions for heart disease, contributing to both clinical and epidemiological understandings within the field of cardiovascular medicine.

Best Publications

  • Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.

    Anne B. Rossebø;Terje R. Pedersen;Kurt Boman;Philippe Brudi

  • Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The Losartan Intervention For End point reduction in hypertension (LIFE) study

    Kristian Wachtell;Mika Lehto;Eva Gerdts;Michael H. Olsen

  • Prognostic significance of left ventricular mass change during treatment of hypertension

    Richard B Devereux;Kristian Wachtell;Eva Gerdts;Krister K. Boman

  • A Call to Action and a Lifecourse Strategy to Address the Global Burden of Raised Blood Pressure on Current and Future Generations: The Lancet Commission on Hypertension

    Michael H. Olsen;Michael H. Olsen;Sonia Y. Angell;Samira Asma;Pierre Boutouyrie

  • Albuminuria and Cardiovascular Risk in Hypertensive Patients with Left Ventricular Hypertrophy: The LIFE Study

    Kristian Wachtell;Hans Ibsen;Michael H. Olsen;Knut Borch-Johnsen

  • Reduction in Albuminuria Translates to Reduction in Cardiovascular Events in Hypertensive Patients. Losartan Intervention for Endpoint Reduction in Hypertension Study

    Hans Ibsen;Michael H. Olsen;Kristian Wachtell;Knut Borch-Johnsen

  • Regression of Hypertensive Left Ventricular Hypertrophy by Losartan Compared With Atenolol: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Trial

    Richard B. Devereux;Björn Dahlöf;Eva Gerdts;Kurt Boman

  • Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis

    Kazem Rahimi;Zeinab Bidel;Milad Nazarzadeh;Emma Copland

  • Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study.

    Lars H. Lindholm;Hans Ibsen;Knut Borch-Johnsen;Michael Hecht Olsen

  • Prevention of Atrial Fibrillation by Renin-Angiotensin System Inhibition: A Meta-Analysis

    Markus P. Schneider;Tsushung A. Hua;Michael Böhm;Kristian Wachtell

  • Risk prediction is improved by adding markers of subclinical organ damage to SCORE.

    Thomas Sehestedt;Jørgen Jeppesen;Tine W. Hansen;Kristian Wachtell

  • Short- and long-term cause of death in patients treated with primary PCI for STEMI.

    Frants Pedersen;Vitalij Butrymovich;Henning Kelbæk;Kristian Wachtell

  • Outcome of Patients With Low-Gradient “Severe” Aortic Stenosis and Preserved Ejection Fraction

    Nikolaus Jander;Jan Minners;Ingar Holme;Eva Gerdts

  • Regression of Electrocardiographic Left Ventricular Hypertrophy and Decreased Incidence of New-Onset Atrial Fibrillation in Patients With Hypertension

    Peter M. Okin;Kristian Wachtell;Richard B. Devereux;Katherine E. Harris

  • Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.

    Kristian Wachtell;Björn Hornestam;Mika Lehto;David J. Slotwiner

  • Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Therapy and Reduction in Sudden Cardiac Death The LIFE Study

    Kristian Wachtell;Peter M Okin;Michael H Olsen;Björn Dahlöf

  • Carotid Intima-Media Thickness Progression as Surrogate Marker for Cardiovascular Risk: Meta-Analysis of 119 Clinical Trials Involving 100 667 Patients

    Peter Willeit;Lena Tschiderer;Elias Allara;Kathrin Reuber

  • Correlates of Left Atrial Size in Hypertensive Patients With Left Ventricular Hypertrophy: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study

    Eva Gerdts;Lasse Oikarinen;Vittorio Palmieri;Jan Erik Otterstad

  • Left Atrial Size and Risk of Major Cardiovascular Events During Antihypertensive Treatment. Losartan Intervention for Endpoint Reduction in Hypertension Trial

    Eva Gerdts;Kristian Wachtell;Per Omvik;Jan Erik Otterstad

  • Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: The LIFE Study

    Hans Ibsen;Kristian Wachtell;Michael H. Olsen;Knut Borch-JohnseN

Frequent Co-Authors

Richard B. Devereux
Richard B. Devereux Cornell University
Björn Dahlöf
Björn Dahlöf Sahlgrenska University Hospital
Markku S. Nieminen
Markku S. Nieminen University of Helsinki
Sverre E. Kjeldsen
Sverre E. Kjeldsen University of Oslo
Peter M. Okin
Peter M. Okin Cornell University
Stevo Julius
Stevo Julius University of Michigan–Ann Arbor
Lars Køber
Lars Køber Copenhagen University Hospital
Giovanni de Simone
Giovanni de Simone University of Naples Federico II
Terje R. Pedersen
Terje R. Pedersen Oslo University Hospital
Christoph A. Nienaber
Christoph A. Nienaber National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medicine, there are several online programs that can broaden your career options in healthcare. A healthcare administration degree online prepares you for vital roles in hospital management, health policy, and operational leadership. This flexible option is ideal if you wish to work on the business side of healthcare.

If you already hold a bachelor’s degree, consider the cheapest online master degree in healthcare administration to further advance your administrative skills and expand your job prospects in the ever-growing healthcare sector.

Nursing professionals looking to move into advanced practice or leadership can explore msn to dnp programs online. These Doctor of Nursing Practice programs help you develop expertise in clinical care, policy, and healthcare systems.

For those interested in pharmacy, an online pharmacy degree provides flexible training to become a licensed pharmacist, blending science, research, and patient care in a rewarding career pathway.

Best Scientists Citing Kristian Wachtell

Trending Scientists

Recently Published Articles